Evidence map›Paper›PMID 40935890›Full record

ArticleNature metabolism2025

Harmonizing human plasma metabolite annotation with Plasma Benchmark.

Ville Koistinen, Topi Meuronen, Pekka Keski-Rahkonen, Reza Salek, Otto Savolainen, Hany Ahmed, Carl Brunius, Rikard Landberg, Marko Lehtonen, Seppo Auriola and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ville Koistinen *Food Sciences Unit, University of Turku, Turku, Finland.
Topi Meuronen *Food Sciences Unit, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0002-8856-0680
Pekka Keski-RahkonenInternational Agency for Research on Cancer (IARC), Lyon, France.ORCID http://orcid.org/0000-0001-9437-3040
Reza SalekInternational Agency for Research on Cancer (IARC), Lyon, France.ORCID http://orcid.org/0000-0001-8604-1732
Otto SavolainenDivision of Food and Nutrition Science, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Hany AhmedFood Sciences Unit, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0002-5876-3970
Carl BruniusDivision of Food and Nutrition Science, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.ORCID http://orcid.org/0000-0003-3957-870X
Rikard LandbergDivision of Food and Nutrition Science, Department of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-6399-7608
Marko LehtonenSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Seppo AuriolaSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Augustin ScalbertInternational Agency for Research on Cancer (IARC), Lyon, France.
Kati HanhinevaFood Sciences Unit, University of Turku, Turku, Finland. kati.hanhineva@utu.fi.ORCID http://orcid.org/0000-0001-6834-7375

Funding

Academy of Finland (Suomen Akatemia) 321716EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 874739World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.